Literature DB >> 15621228

Modulation of porosity in apatitic cements by the use of alpha-tricalcium phosphate-calcium sulphate dihydrate mixtures.

Enrique Fernández1, Maria Daniela Vlad, Maria Montserrat Gel, Jose López, Ricardo Torres, Juan V Cauich, Marc Bohner.   

Abstract

Calcium phosphate bone cements are injectable biomaterials that are being used in dental and orthopaedic applications through minimally invasive surgery techniques. Nowadays, apatitic bone cements based on alpha-tricalcium phosphate (alpha-TCP) are of special interest due to their self-setting behaviour when mixed with an aqueous liquid phase. In this study, a new method to improve osteointegration of alpha-TCP-based cements is presented. This method consists in the modification of the cement's powder phase with different amounts of calcium sulphate dihydrate (CSD). The resulting hardening properties of the new biphasic cements are a combination between the progressive hardening due to the main alpha-TCP reactant and the progressive dissolution of the CSD phase, which render a porous material. It was observed that the maximum compressive strength of Biocement-H (45 MPa) decreased as the amount of CSD increased in the cement powder mixture ( approximately 30 MPa for 25 wt% of CSD). It was also observed that after complete dissolution of the CSD phase a porous apatitic structure appears with a mechanical compressive strength suitable for cancellous bone applications (10 MPa).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621228     DOI: 10.1016/j.biomaterials.2004.09.023

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  Injectable iron-modified apatitic bone cement intended for kyphoplasty: cytocompatibility study.

Authors:  M D Vlad; L J del Valle; I Poeata; M Barracó; J López; R Torres; E Fernández
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

2.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 3.  Injectable foams for regenerative medicine.

Authors:  Edna M Prieto; Jonathan M Page; Andrew J Harmata; Scott A Guelcher
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-11

Review 4.  Calcium silicate-based cements and functional impacts of various constituents.

Authors:  Mohammad Ali Saghiri; Jafar Orangi; Armen Asatourian; James L Gutmann; Franklin Garcia-Godoy; Mehrdad Lotfi; Nader Sheibani
Journal:  Dent Mater J       Date:  2016-10-22       Impact factor: 2.102

5.  Performance of calcium deficient hydroxyapatite-polyglycolic acid composites: an in vitro study.

Authors:  Nicholas Dunne; Valerie Jack; Rochelle O'Hara; David Farrar; Fraser Buchanan
Journal:  J Mater Sci Mater Med       Date:  2010-03-05       Impact factor: 3.896

6.  Strong, macroporous, and in situ-setting calcium phosphate cement-layered structures.

Authors:  Hockin H K Xu; Elena F Burguera; Lisa E Carey
Journal:  Biomaterials       Date:  2007-05-26       Impact factor: 12.479

7.  Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using chitosan and citric acid.

Authors:  Ho-Yeon Song; A H M Esfakur Rahman; Byong-Taek Lee
Journal:  J Mater Sci Mater Med       Date:  2008-12-04       Impact factor: 3.896

8.  Study on injectable and degradable cement of calcium sulphate and calcium phosphate for bone repair.

Authors:  Gangfeng Hu; Luwei Xiao; Hong Fu; Dawei Bi; Haitao Ma; Peijian Tong
Journal:  J Mater Sci Mater Med       Date:  2009-10-13       Impact factor: 3.896

9.  Application of impedance spectroscopy to evaluate the effect of different setting accelerators on the developed microstructures of calcium phosphate cements.

Authors:  H E Romeo; P R Bueno; M A Fanovich
Journal:  J Mater Sci Mater Med       Date:  2009-04-04       Impact factor: 3.896

10.  A new biphasic osteoinductive calcium composite material with a negative Zeta potential for bone augmentation.

Authors:  Ralf Smeets; Andreas Kolk; Marcus Gerressen; Oliver Driemel; Oliver Maciejewski; Benita Hermanns-Sachweh; Dieter Riediger; Jamal M Stein
Journal:  Head Face Med       Date:  2009-06-13       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.